News Quantified

INNV – innovage holding corp. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

InnovAge (NASDAQ:INNV) had its price target raised by analysts at JPMorgan Chase & Co. from $5.00 to $7.00. They now have an "underweight" rating on the stock.

InnovAge (NASDAQ:INNV) was upgraded by analysts at Weiss Ratings from a "sell (d-)" rating to a "hold (c-)" rating.

InnovAge (NASDAQ:INNV) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.

Assessing InnovAge Holding (INNV) Valuation After Recent Share Price Volatility [Yahoo! Finance]

Proven Senior Care Model Takes Center Stage at the Capitol

37.5%

BEAT

-17.6%

BEAT

-4.8%

BEAT

14.4%

MISS

Form 10-Q InnovAge Holding Corp. For: Dec 31

Form 8-K InnovAge Holding Corp. For: Feb 03

Form 3 InnovAge Holding Corp. For: Jan 28 Filed by: TRAYNOR SEAN

Form 3 InnovAge Holding Corp. For: Jan 28 Filed by: MAHESH PAVITHRA

Form 8-K InnovAge Holding Corp. For: Jan 28

Top News Gainers

5/31 Form 8-K INNOVUS PHARMACEUTICALS, For: May 28 14.5%

1/15 Form SC 13G INNOVUS PHARMACEUTICALS, Filed by: LGH Investments, LLC 11.6%

8/9 Innovus Pharmaceuticals to Release Second Quarter 2019 Financial Results and Provide Corporate Update on Tuesday, August 13, 2019 11.6%

9/23 Form 425 INNOVUS PHARMACEUTICALS, Filed by: AYTU BIOSCIENCE, INC 8.4%

6/4 Innovus Pharma Expands its OTC Drug Pipeline with the Addition of OmepraCare™ (a Competitor of Prilosec® OTC) 7.3%

2/14 Form 8-K INNOVUS PHARMACEUTICALS, For: Feb 13 6.0%

6/19 Innovus Pharmaceuticals Announces Progress in Fulfilling the Regulatory and Manufacturing Steps to Receive Market Authorization for FlutiCare® in Canada 5.6%

9/13 Form 425 INNOVUS PHARMACEUTICALS, Filed by: INNOVUS PHARMACEUTICALS, INC. 3.8%

5/8 Innovus Pharma Announces a Second Partnered United States OTC ANDA for Minoxidil 5% Foam for Men and Women 3.4%

5/28 Following Its Recent Approval from Health Canada for the Relief of Neuropathy Pain, Innovus Pharma Announces Receipt of Notification to Commercialize Diabasens® in the European Union 3.4%

Top News Decliners

5/15 Innovus Pharma Reports Quarterly Revenue for the First Quarter 2019 of $5.4 Million, a 18.0% Increase from Comparable Quarter in the Prior Year -15.1%

8/13 Innovus Pharma Reports Quarterly Revenue for the Second Quarter 2019 of $6.8 million, a 27.7% Increase from Prior Quarter -10.1%

6/10 Form S-8 INNOVUS PHARMACEUTICALS, -8.1%

9/18 Form 3 INNOVUS PHARMACEUTICALS, For: Sep 13 Filed by: Armistice Capital Master Fund Ltd. -7.9%

9/17 Innovus Pharmaceuticals Inc (OTCMKTS: INNV) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $5.00 price target on the stock. -6.9%

11/15 Innovus Pharmaceuticals Inc (OTCMKTS: INNV) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $5.00 price target on the stock. -6.1%

5/6 Innovus Pharmaceuticals Reports Preliminary Q1 2019 Sales Revenue of Approximately $5.4 million -5.7%

5/13 Innovus Pharma’s Partner Lavasta Receives Approval from Algeria to Market and Sell Zestra® and Zestra Glide® in that Country -2.2%

7/22 Form 8-K INNOVUS PHARMACEUTICALS, For: Jul 22 -1.9%

6/6 Innovus Pharmaceuticals Receives Notification to Market and Sell CarvaNum® for Muscle Recovery in the European Union -1.5%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day